The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition

Attention: There is an updated edition available for this report.
   Single User - $1,995
   Department License - $2,995
   Corporate License - $3,990

Published Aug 13, 2014 | 1200 Pages | Pub ID: KLI5309370

The in vitro diagnostics  (IVD) market attracts considerable interest.  There are hundreds of participating companies, competing in multiple areas of testing.  Each IVD segment could be said to function as an industry in and of itself.  There are companies who specialize in one area and companies who participate across segments.  There are myriad products, from routine blood tests to complicated molecular assays and new sequencing based technologies.  It's often necessary for competitors to know about all of the segments of testing as different technologies can often compete.  This single volume Kalorama Information report has been written and updated for over a decade in nine editions, with the purpose of keeping readers informed about developments in clinical testing.  It covers the entirety of the clinical testing market, reports on hundreds of competitors, details deals and acquisitions and computes market size statistics for important segments.   Published every two years, this volume includes recent market size and forecasts to 2018 for the most important aspects of all of the major segments of clinical lab testing, including

  • Clinical Chemistry and "Core Lab" Markets (including sub segment revenues for General Chemistries, Workstations, Analyzers Blood Gases, Urinalysis, Critical Care)
  • Near-Patient and Point of Care Testing (POC), (Professional and Self-Testing, Glucose Testing, Pregnancy Tests, drugs of abuse, HIV, H. pylori, Other, OTC/Self Total, Professional POC, Cardiac Markers, Drugs of Abuse, HbA1c, Pregnancy, Other)
  • Tissue-Based Testing - Histology and Cytology (Pap, ISH, IHC, HPV)
  • Microbiology Immunoassay Testing  (Hepatitis, HIV, STDs, TORCH, Respiratory, Sepsis, Parasitology, Mycology, Others)
  • Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, Pharmacodiagnostics, Tissue Typing, Prenatal)
  • Hematology
  • Molecular Tests in Infectious Diseases (HAI, HIV, Hepatitis, GC/Chlamydia, Respiratory, Organism ID, Mycobacteria, TB, Others
  • Non-Infectious Disease Immunoassay Sales by Analyte Type (Cardiac markers, Tumor markers, Diabetes/HbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic drugs, Tox/Drugs of abuse, Vitamin D)
  • Coagulation Tests (Lab-Based, POC, Genetic Markers)
  • Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases - DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies)
  • Blood Banking (Grouping, Immunoassay Screens, NAT Screens)
No other report provides an similar sense of the world diagnostics market.   Shara Rosen (MBA, RT)  has edited nine editions of this superior work intended to provide IVD market coverage in a world perspective.  A month's long research effort creates authoritative market estimates and forecasted growth models for in vitro diagnostic (IVD) testing products throughout the world.

This is a global report.  The following IVD markets are included:

  • North America
  • Europe (with total IVD market sizes for EU countries)
  • Asia (China, Japan, India)
  • Latin America
  • Emerging Markets
  • Rest of World

Not Just "Who Did What?"  This Report Answers "What are the Reasons Behind the Results"

The report does just report on deals, events in the industry, laboratory trends and corporate results.  It provides that information, but it also analyzes why trends are occurring, and what readers can expect in the future.   

The Worldwide Market for In Vitro Diagnostic Tests is a testament to the Kalorama methodology. It is the result of months of painstaking work by an IVD industry veteran, who has tracked hundreds of companies for developments, trends and financial results. This research is compiled along with the opinion, observations and insights of industry experts to produce an unparalleled vision of the industry as it is in 2014. The report includes data in a sizeable number of IVD segments and detailed discussion of the trends that are impacting the industry. The report also provides a realistic forecast five years into the future for companies already participating in or considering entry into this growing industry.  Many top IVD companies have purchase this volume and use the data within for their business planning efforts. 

The same business intelligence top companies possess is available to purchasers of this unique report.

The report contains detailed profiles of the top players in IVD. Profiling in this report describes the developments in each significant division of their business. A number of secondary players are also extensively profiled, as well as specialty companies with expertise in one testing area.
  • Abbott Diagnostics
  • Alere Inc.
  • Arkray
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company (BD)
  • bioMérieux Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Hologic, Inc.
  • Ortho Clinical Diagnostics (OCD)
  • Siemens Healthcare Diagnostics
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Affymetrix Inc.
  • Cepheid
  • Eiken Chemical Co., Ltd
  • ERBA Diagnostics, Inc.
  • DiaSorin S.p.A
  • Fujirebio Diagnostics, Inc.
  • Illumina
  • LabCorp
  • Luminex Corporation
  • Roche Diagnostics
  • Wako Pure Chemical Industries
And hundreds of other companies...
All market data are based on factory sales to the end user and not retail pricing or reimbursement payments. Data for the in vitro diagnostic market are presented in U.S. dollar market size for categories of tests, and for specific analytes where possible. The dollar value of a market segment is directly proportional to the number of tests performed, because the cost of the instrumentation is generally buried in the per test price.

The information presented in this report is derived on publicly available information sources such as company, government, and medical organization reports. The analysis is based on the author's industry knowledge combined with literature searches and interviews with industry professionals and experts in the IVD industry.
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times